Aden Pharmaceuticals Private Limited, a active private limited company, was established on 28 August 2006 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24232GJ2006PTC048957. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹2.00 M.
It upholds a compliant status. Employing 31 professional, Its leadership includes Hasmukhbhai Madhabahi Antala (Director), Ashokbhai Gobarbhai Savalia (Director), Dilipkumar Shambhubhai Dholaria (Director). Past directors included Alpaben Hasmukhbhai Antala, Bharti Ashok Savalia, Maheshkumar Vallabhbhai Savaliya. It holds ₹7.42 Cr open charges and ₹10.18 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Block No. 563 /A, Ecpl Road, At. Dudhvada, Ta. Padra, Vadodara, Gujarat, 391450.
U24232GJ2006PTC048957
048957
28 August 2006
₹5.00 M
₹2.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Aden Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hasmukhbhai Madhabahi Antala | Director | 03 Jan 2008 | Current |
| Ashokbhai Gobarbhai Savalia | Director | 28 Aug 2006 | Current |
| Dilipkumar Shambhubhai Dholaria | Director | 28 Aug 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
| Pramod Abcsdd | Director | 03 Jan 2008 | Past |
| Pramod Abcsdd | Director | 01 Apr 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aden Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.91% decrease. The company also saw a substantial improvement in profitability, with a 114.08% increase in profit. The company's net worth moved up by a moderate rise of 1.62%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Aden Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹74,196,000.00
₹101,812,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Dec 2024 | Bank Of India | ₹3.71 Cr | Open |
| 27 Feb 2024 | Bank Of India | ₹3.71 Cr | Open |
| 12 May 2017 | Others | ₹3.43 Cr | Satisfied |
| 11 Apr 2017 | Others | ₹2.30 Cr | Satisfied |
| 02 Apr 2013 | Bank Of India | ₹1.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Aden Pharmaceuticals has a workforce of 31 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aden Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aden Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Bank Of India amounted to Rs. 37.10 M with Charge ID 101017024 was registered on 05 Dec 2024. was documented.
A charge with Bank Of India of Rs. 37.10 M registered on 27 Feb 2024 with Charge ID 100872116 was modified on 05 Dec 2024. was recorded as a recent event.
Progress on Aden Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Aden Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was recorded as a recent event.
Progress on A charge registered on 02 Apr 2013 via Charge ID 10422836 with Bank Of India was fully satisfied on 14 Mar 2024. was documented.
A charge registered on 06 Dec 2008 via Charge ID 10135028 with Bank Of India was fully satisfied on 14 Mar 2024. was recorded as a recent event.
The CIN of Aden Pharmaceuticals Private Limited is U24232GJ2006PTC048957.
Aden Pharmaceuticals Private Limited is headquartered at Block No. 563 /A, Ecpl Road, At. Dudhvada, Ta. Padra, Vadodara, Gujarat, 391450.
Aden Pharmaceuticals Private Limited was incorporated on 28 August 2006.
The current directors of Aden Pharmaceuticals Private Limited are
The primary industry of Aden Pharmaceuticals Private Limited is Manufacturing.
Aden Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aden Pharmaceuticals Private Limited is ₹5.00 M, and the paid-up capital is ₹2.00 M.
The compliance status of Aden Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX